Jazz Pharmaceuticals (JAZZ) Reports In-Line Q4 EPS, FY Guidance Comes in Light
Go back to Jazz Pharmaceuticals (JAZZ) Reports In-Line Q4 EPS, FY Guidance Comes in Light| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 227.40 +1.48 (0.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $225.92 | 52 Week High | $160.00 | |||
| Open | $225.27 | 52 Week Low | $95.80 | |||
| Day High | $228.51 | P/E | 42.27 | |||
| Day Low | $222.93 | EPS | $5.38 | |||
| Volume | 419,592 | |||||
